
Sign up to save your podcasts
Or


Dr. Linda Chu welcomes Dr. Robert McDonald (Mayo Clinic) and Dr. Paul Evans (GE HealthCare) for a discussion on the evolution of MR contrast agents, exploring how gadolinium has changed MRI diagnostics and what decades of clinical experience have taught the radiology community. The conversation also looks ahead to emerging contrast technologies, including iron and manganese based agents and other innovations that could shape the future of MR imaging, safety, and sustainability.
Sponsored by GE HealthCare
Dr. Reni Butler speaks with Dr. Bryan Haslam, Dr. Greg Sorensen, Dr. Matt McCabe, and Dr. Christoph Lee about their large real-world study evaluating an AI driven workflow for screening mammography across 109 U.S. facilities. Together, they explore how AI helped general radiologists achieve cancer detection and recall performance comparable to breast imaging specialists, as well as the broader implications for patient care, workflow design, and the future of precision screening.
Closing the Performance Gap between Generalists and BreastImaging Specialists Using a Nationally Deployed AI Workflowfor Screening Mammography. McCabe et al. Radiology 2026; 320(1):e252005.
Dr. Ashwin Parihar speaks with Dr. Olayinka A. Abiodun-Ojo and Dr. David M. Schuster about findings from the EMPIRE 2 trial, exploring how fluciclovine PET and PSMA PET influence salvage radiotherapy planning for men with recurrent prostate cancer after prostatectomy. The discussion examines the strengths and limitations of each tracer, the importance of prostate bed detection, and where fluciclovine may still have a role in the evolving era of PSMA-targeted imaging.
18F-Fluciclovine or 68Ga-PSMA-11 PET/CT–guided SalvageRadiotherapy Changes in Postprostatectomy BiochemicalRecurrence: Secondary Analysis of the EMPIRE-2 Trial. Abiodun-Ojo and Jani et al. Radiology 2026; 319(3):e251874.
Dr. Lauren Kim speaks with first author Dr. Andrew Hernandez about his study which comprehensively quantified energy consumption in MRI, CT, and PET/CT imaging suites by measuring the energy utilization of main power, HVAC, and chilled water subsystems. The study showed that HVAC and chilled water subsystems contribute substantially to total energy consumption, that energy efficiency increases with increasing daily scanning volume, and that a substantial portion of energy consumption occurs during non-operating hours.
Quantification of Imaging Suite–Level Energy Patterns in MRI, CT, and PET/CT to Guide Energy Efficiency. Hernandez et al. Radiology 2026; 319(1):e253128.Dr. Lauren Kim and first author Dr. Daniel Marinescu discuss this study comprised of approximately 1,500 patients which determines the relative importance of specific CT imaging features used to distinguish radiologic patterns in fibrotic interstitial lung disease. This study identifies areas of substantial incongruence between radiologist-assigned ILD patterns and current clinical diagnostic guideline definitions, incongruencies which in turn may help refine and standardize future diagnostic criteria.
Association of CT Features with Radiologic Patterns in Interstitial Lung Disease: Multinomial Analysis in CARE-PF. Marinescu et al. Radiology 2026; 318(3):e251944.
From CT Features and Patterns to Clinical Pathways: Focusing a Multinomial Lens on Fibrotic ILD. Czum and Brown. Radiology 2026; 318(3):e260494.
From the publisher's feed

30,707 Listeners

10,903 Listeners

7,606 Listeners

4,116 Listeners

1,044 Listeners

499 Listeners

2,443 Listeners

111,852 Listeners

16,131 Listeners

28 Listeners

46 Listeners

6,057 Listeners

210 Listeners

13 Listeners

41 Listeners